Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 315 | 322 | 188 | 0 | 0 |
| Gross Profit | 315 | 322 | 188 | N/A | N/A |
| Operating Expenses | 981 | 1,400 | 1,188 | 1,222 | 1,047 |
| Operating Income | -666 | -1,078 | -1,000 | -1,222 | -1,047 |
| Interest Expense | 46 | 38 | 31 | 505 | 4 |
| Other Income | -1 | 38 | 0 | 489 | -1 |
| Pre-tax Income | -713 | -1,078 | -1,031 | -1,239 | -1,051 |
| Net Income Continuous | -713 | -1,078 | -1,031 | -1,239 | -1,051 |
| Net Income | $-713 | $-1,078 | $-1,031 | $-1,239 | $-1,051 |
| EBITDA(a) | $-663 | $-1,075 | $-997 | $-1,219 | $-1,044 |